A consortium working in capacity building for #Tuberculosis researchers in #Paraguay and #Europe. Aim is building a Latin American TB research site and #EndTB
Our “Call for action for high prevalence of TB among people deprived of liberty” is online:
https://t.co/YeKrxDH56N
@EusatTb@CecileMagis@RaquelAFDuarte
Prevalencia alta de tuberculosis en las prisiones de Paraguay.
Es necesaria una acción rápida para evitar esta crisis inminente y garantizar la salud y seguridad de todas las personas dentro del sistema penitenciario y más allá.
1 de cada 15 hombres tiene Tuberculosis activa.
Sky high prevalence of tuberculosis in Paraguayan prisons.
Swift action is necessary to avert this impending crisis and ensure the health and safety of all individuals within the prison system and beyond.
1 out of 15 males with active tuberculosis.
#WorldTBDay@EspinosaPereiro will give a lecture on TB treatment @ INARAM hospital in Asuncion, Paraguay. By doing so, he will inspire and educate other young doctors in Paraguay. This is one of the many great examples of knowledge sharing and capacity building, within EUSAT-RCS!
Today is #WorldTBDay . In our #RISE consortium, we do research on #diagnosis and #treatment of TB in hard to reach and vulnerable populations which are severely affected but often overlooked. Read more on our website https://t.co/KYjZGkiXx4
Day 2 of the Annual Meeting: We welcomed international speakers at @IndexSaci and on ZOOM during our #InternationalSympsosium. Speakers of @imi_eupearl , @INNOVA4TB , PhD cadidate Chari Coronel, and Guillermo Sequera of Paraguay's MoH presented on various topics. Thanks all!
Monday, the kick-off of EUSAT’s Annual Meeting 2023 took place in Asuncion, Paraguay! We had a day full of workpackage presentations, discussions, food and laughter. Thanks to all the speakers and attendees for this good start of EUSAT’s Annual Meeting 2023!
After a long pandemic silence we’re back on track! Last May, we had our annual meeting @radboudumc. It was an inspiring meeting with our colleagues from @ISPUP, @taskapplied, @VHIR_, @umcg, @ElectronicNose ! Thank you! Let’s keep this spirit and #endTB together!
https://t.co/mF2o7Fmnc8 You can now read the EDCTP Annual Report of 2019. It features the PanACEA phase 2 study of BTZ-043, a promising chemical entity for TB treatment #TB @LMU_Uniklinikum @EDCTP
20 years ago, amid a global resurgence of #tuberculosis, organizations gathered in South Africa and issued the Cape Town Declaration, which led to the creation of TB Alliance. Over the last 20 years, we've worked together to #endTB: https://t.co/suWyeCzal1 #20YearsofImpact
As the world grapples with #COVID19, we are convening a virtual panel to reflect on the future of infectious disease product development and pandemic response. Register here ➡️ https://t.co/ybIX6HfE3u
Happening Tomorrow!
We will be co-hosting the launch of the @GCTA TB Human Rights Policy Brief. Please join the virtual launch with TB survivors & leaders.
🗓️21 July 2020
👉https://t.co/K8K1y6YEPU
#EndTB#humanrights
“We have known how to cure TB for more than 50 years. What we have lacked is the will and the resources to quickly diagnose people with TB and get them the treatment they need”- @NelsonMandela survived TB in prison & campaigned for people with #TB & #HIV.
#MandelaDay#EndTB
Proud to co-host the launch of the @GCTA TB Human Rights Policy Brief. @StopTB has championed #TBrights, gender issues, & #nostigma as essential steps toward realising #unhlmtb targets.
Please join the virtual launch with amazing TB survivors & leaders 👉https://t.co/K8K1y6YEPU
INVITATION: This Thursday 16 July at 15.00h (CEST) KNCV will present a new webinar: 'Impact of COVID-19: The perspective of TB/MDR-TB patients and front line health care workers���. Join us by following this link: https://t.co/42BgNJVHhP